Registered Address
Registered Office : Sun Pharma Advanced Research Centre (SPARC), Tandalja,
|
Vadodra, Gujarat - 390012
|
Tel: 0265-6615500, 6615600, 6615700
|
Fax: 0265-2354897
|
Email :
secretarial@sunpharma.com
|
Website :
http://www.sunpharma.com
|
Key Officials
Name
|
Designation
|
Mr. C S Muralidharan
|
Chief Financial Officer
|
Mr. Abhay Gandhi
|
CEO - North America
|
Dr. Uday Baldota
|
CEO - Taro Pharmaceutical Industries Ltd.
|
Listings
BSE , BSE , MCXSX , NSE , NSE ,
|
|
Quarterly
Trends - Standalone
|
Rs. in Crs.
|
Financial Year | Dec 23 | Sep 23 | Jun 23 |
Sales | 5,073.75 | 5,096.21 | 4,466.07 |
Other Income | 76.80 | 106.54 | 163.54 |
Total Expenses | 3,487.55 | 3,445.24 | 3,304.25 |
Depreciation | 399.60 | 392.71 | 415.27 |
Taxation | 30.16 | 17.89 | 9.24 |
Net Profit / Loss | 721.31 | 888.63 | 380.64 |
Equity Capital | 239.93 | 239.93 | 239.93 |
|
Half Yearly Balance Sheet - Standalone
|
Rs. in Crs.
|
YearEnding | Mar 23 | Mar 22 | Mar 21 |
Face Value | 1 | 1 | 1 |
Equity Share Capital | 239.93 | 239.93 | 239.93 |
Reserves and Surplus | 23508.43 | 24348.02 | 24800.23 |
Total Non-Current Liabilities | 8873.07 | 6071.70 | 5615.12 |
Total Current Liabilities | 8366.06 | 10105.83 | 8343.55 |
Total Capital And Liabilities | 40987.49 | 40765.48 | 38998.83 |
Total Non-Current Assets | 24522.34 | 31061.73 | 26932.49 |
Total Current Assets | 16465.15 | 9703.75 | 12066.34 |
Total Assets | 40987.49 | 40765.48 | 38998.83 |
|
|
Quarterly
Trends - Consolidated
|
Rs. in Crs.
|
Financial Year | Dec 23 | Sep 23 | Jun 23 |
Sales | 12,380.70 | 12,192.41 | 11,940.84 |
Other Income | 250.20 | 293.61 | 204.44 |
Total Expenses | 8,107.38 | 8,006.21 | 7,929.11 |
Depreciation | 622.14 | 632.82 | 651.32 |
Taxation | 432.32 | 390.10 | 468.10 |
Net Profit / Loss | 2,568.03 | 2,400.78 | 2,013.04 |
Equity Capital | 239.93 | 239.93 | 239.93 |
|
Half Yearly Balance Sheet - Consolidated
|
Rs. in Crs.
|
YearEnding | Mar 23 | Mar 22 | Mar 21 |
Face Value | 1 | 1 | 1 |
Equity Share Capital | 239.93 | 239.93 | 239.93 |
Reserves and Surplus | 55755.45 | 47771.29 | 46222.85 |
Minority Interest | 3320.09 | 3054.89 | 3017.05 |
Total Non-Current Liabilities | 1521.12 | 1533.21 | 2041.27 |
Total Current Liabilities | 19907.00 | 17200.55 | 16145.63 |
Total Capital And Liabilities | 80743.59 | 69799.87 | 67666.73 |
Total Non-Current Assets | 40860.25 | 34784.89 | 37224.65 |
Total Current Assets | 39883.34 | 35014.98 | 30442.08 |
Total Assets | 80743.59 | 69799.87 | 67666.73 |
|
Corporate News
|
|
Registrar Details
Link Intime India Pvt. Ltd.
|
C 101, 247 Park,
L.B.S. Marg, Vikhroli (West)
|
Mumbai,400083,Maharashtra
|
Tel : 022-49186270
|
Fax : 49186060
|
Market Performance
Exchange
|
BSE
|
NSE
|
Last Traded Price (Rs.)
|
1,620.50
|
1,620.55
|
Last Traded Date
|
28/03/2024
|
28/03/2024
|
Last Traded Time
|
-
|
-
|
Change (%)
|
0.77%
|
1.02%
|
Day's Open (Rs.)
|
1,605.40
|
1,609.95
|
Previous Close (Rs.)
|
1,608.10
|
1,604.15
|
Day's High (Rs.)
|
1,634.05
|
1,634.00
|
Day's Low (Rs.)
|
1,605.40
|
1,607.95
|
Total Traded Qty
|
300264
|
4427587
|
Value (Rs. In Lacs)
|
4876.08
|
71879.20
|
Bid Price (Rs.)
|
0.00
|
0.00
|
Bid Quantity
|
|
|
Offer Price (Rs.)
|
0.00
|
0.00
|
Offer Quantity
|
|
|
Exchange Code
|
524715
|
SUNPHARMAEQ
|
Exchange Group
|
A
|
Nifty
|
Board Meetings
Date
|
Purpose
|
31/01/2024
|
Quarterly Results & Interim Dividend
|
01/11/2023
|
Quarterly Results
|
03/08/2023
|
Quarterly Results
|
Share Holding Pattern as on 31/12/2023
Major Holder
|
No. of Shares
|
Percentage (%)
|
Promoters
|
1,307,134,535
|
54.48
|
Institutional Investors
|
878,137,050
|
36.60
|
Other Investors
|
84,185,478
|
3.51
|
General Public
|
129,877,907
|
5.41
|
|